Zusammenfassung
Das Charles Bonnet Syndrom (CBS) wird definiert als das Auftreten von visuellen Halluzinationen (VH) ohne psychopathologische Erkrankungen. Von dieser Erkrankung sind hauptsächlich ältere Patientinnen und Patienten betroffen, die aufgrund ihres geringen Visus bedingt durch ophthalmologische Pathologien (meist durch die altersbedingte Makuladegneration – AMD) VH erleiden. Zur Prävalenz des CBS im europäischen Raum können viele unterschiedliche Ergebnisse gefunden werden. Mehr über diese Erkrankung zu lernen ist essentiell, um gegebenenfalls die Symptome zu erkennen, richtig zu deuten und betroffenen Patienten adäquate Information und Therapie zu kommen zu lassen. Genaue und einheitliche diagnostische Kriterien für ein CBS sind die Grundlage weiterer Studien.
Summary
A Charles Bonnet Syndrome (CBS) is defined by the occurence of visual hallucinations (vh) in the absence of any mental disorder. Elderly patients with reduced visual acuity due to ophthalmic diseases are most affected. Conditions often associated with the syndrome are age-related macular degeneration (AMD), cataract and glaucoma. Existing data on the syndrome’s prevalence in Europe reveal diverse results. It is essential for people involved with patients suffering from severe vision loss to learn more about the Charles Bonnet Syndrome. This will make it easier to identify and interpret symptoms correctly and might also lead to a more adequate information and therapy for affected patients. For further studies precise and standardised diagnostic criteria should be defined.
Literatur
Olbrich HM, Engelmeier MP, Pauleikhoff D, Waubke T. Visual hallucinations in Ophtalmology. Graefe’s Archive for. Clin Exp Ophthalmol. 1987;225(3):217–20.
Lerrario A, Ciammola A, Poletti B, Girotti F, Silani V. Charles Bonnet syndrome: two case reports and review of the literature. J Neurol. 2013;260(4):1180–6.
Eperjesi F, Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom. 2004;87:3:149–52, May.
O’Farrell L, Lewis S, McKenzie A, Jones L. Charles Bonnet Syndrome: A Review of the Literature. J Vis Impair Blind. 2010;104(5):261–74, May.
Jan T, del Castillo J. Visual Hallucinations: Charles Bonnet Syndrome. West J Emerg Med. 2012;13(6):544–7.
Paradowski B, Kowalzyk E, Chojdak-Lukasiewicz J, Loster-Niewinska A, Sluzewska-Niedzwiedz M. Three Cases with Visual Halluzinations following Combined Ocular and Occipital Damage. Case Reports in Medicine 2013; Volume 2013, Article ID 450725, 5 pages.
Teunisse R, Cruysberg JRM, Verbeek A, Zitman FG, Bonnet Syndrome TC. A Large Prospective Study in The Netherlands. A Study of the Prevalence of the Charles Bonnet Syndrome and Associated Factors in 500 Patients Attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry. 1995;166:254–7.
Schultz G, Melzack R. The Charles Bonnet syndrome: „Phantom images“. Perception. 1991;20:809–25.
Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: The Charles Bonnet syndrome. Surv Ophthalmol. 2003;48:58–72.
Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet. 1996;347(9004):794–7.
Vale TC, Fernandes LC, Caramelli P. Charles Bonnet syndrome: chararcteristics of its visual hallucinations and differential diagnosis. Arq Neuropsiquiatr. 2014;72(5):333–6.
Gold K, Rabins RV. Isolated visual hallucinations and the Charles Bonnet syndrome: A review of the literature and presentation of six cases. Compr Psychiatry. 1989;30:90–8.
Tan CSH, Lim VSY, Ho DYM, Yeo E, Ng BY, Au Eong KG. Charles Bonnet syndrome in Asian patients in a tertiary ophtalmic centre. Br J Ophthalmol. 2004;88:1325–9.
Abbott EJ, Connor GB, Artes PH, Abadi RV. Visual Loss and Visual Hallucinations in Patients with Age-Related Macular Degeneration (Charles Bonnet Syndrome). Investigative Ophthalmology. Vis Sci. 2007;48(3):1416–23.
Collerton D, Perry E, McKeith I. Why people see things that are not there: A novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005;28:737–94.
Teeple RC, Caplan JP, Stern TA. Visual Hallucinations: Differential Diagnosis and Treatment. J Clin Psychiatry. 2009;11(1):26–32.
Lannon SP, Stevenson MR, White ST, Logan JF, Reinhardt-Ruthland AH, Jackson AJ. Visual hallucinations in patients with age-related macular degeneration (AMD). Vis Impair Res. 2006;8((1–2):9–16.
Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol. 2001;131(5):590–8.
Holroyd S, Rabins PV, Finkelstein D, Lavrisha M. Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis. 1994;182:273–6.
Höflich A, Baldinger P, Lanzenberger R, Kasper S, Winkler D. Steckbrief seltener Krankheiten: Das Charles Bonnet-Syndrom. J Für Neurol Neurochir Psychiatr. 2012;13(4:187–9.
Elbers N, Geraerts E, van Heerden J. Hallucinating consistency. Theory Psychol. 2007;17:587–602.
Siatkowski RM, Zimmer B, Rosenberg PR, Bonnet Syndrome TC. Journal of Clinical Neuro-ophthalmology. Vis Perceptive Dysfunct Sens Deprivation. 1990;10(3):215–8.
ffytche DH. Visual hallucinatory syndromes: past, present and future. Dialogues in Clinical Neuroscience 2007; Volume 9, No. 2: 173–189.
Santhouse AM, Howard RJ. ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain – A J Neurol. 2000;123:2055–64.
Cox TM. ffytche DH. Negative outcome Charles Bonnet Syndrome. Br J Ophthalmol. 2014; doi:10.1136/bjophthalmol-2014-304920.
ffytche DH, Howard RJ. The perceptual consequences of visual loss: ‚positive‘ pathologies of vision. Brain – A Journal of Neurology 1999; July: 122, 1247–1260.
Jackson ML, Bassett K, Nirmalan PV, Sayre EC. Contrast sensitivity and visual hallucinations in patients referred to a low vision rehabilitation clinic. Br J Ophthalmol. 2007;91:296–8.
Zhang H, Liu ZL, Sun P, Gu F. Incidence of Charles Bonnet syndrome after intravitreal bevacizumab injection in neovascular age-related macular degeneration. Acta Ophthalmol (Copenh). 2012;90(8):e647–e648.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
B. Döller und O. Findl geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Döller, B., Findl, O. Prävalenz des Charles Bonnet Syndroms – eine Übersicht der Literatur. Spektrum Augenheilkd. 31, 2–5 (2017). https://doi.org/10.1007/s00717-017-0331-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00717-017-0331-3
Schlüsselwörter
- Charles Bonnet Syndrom
- Visuelle Halluzinationen
- Altersbedingte Makuladegeneration
- Prävalenz
- Literaturübersicht